← Back to Search

Other

Blood Flow Restriction (BFR) for Healthy Subjects

N/A
Recruiting
Research Sponsored by Cedars-Sinai Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up measured at 4,6,8,12 and 16 weeks.
Awards & highlights

Study Summary

This trial is testing how well a low-load exercise routine works at strengthening muscles compared to conventional methods.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~measured at 4,6,8,12 and 16 weeks.
This trial's timeline: 3 weeks for screening, Varies for treatment, and measured at 4,6,8,12 and 16 weeks. for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
The change in Force plate measures from baseline to 16 weeks
the change in Force plate measures from baseline to 16 weeks
the changes in Force Frame measure from baseline to 16 weeks
+2 more

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Group 2 - Low-load BFR groupExperimental Treatment2 Interventions
Participants will warm up on a stationary bike for 5 minutes BFR will be applied to non-dominant limb (dominant limb is determined as the preferred leg for kicking a ball) The program will consist of the following exercises using a 30,15,15,15 rep scheme: Banded squats Step ups (8 inch) Romanian dead lifts (RDL)
Group II: Group 1 - Standard strengthening group (no BFR)Active Control1 Intervention
Participants will warm up on a stationary bike for 5 minutes The program will consist of the following exercises using a 30,15,15,15 rep scheme: Banded squats Step ups (8 inch) Romanian dead lifts (RDL)
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
BFR
2019
N/A
~30

Find a Location

Who is running the clinical trial?

Cedars-Sinai Medical CenterLead Sponsor
499 Previous Clinical Trials
164,839 Total Patients Enrolled

Media Library

BFR (Other) Clinical Trial Eligibility Overview. Trial Name: NCT05868304 — N/A
Healthy Subjects Research Study Groups: Group 1 - Standard strengthening group (no BFR), Group 2 - Low-load BFR group
Healthy Subjects Clinical Trial 2023: BFR Highlights & Side Effects. Trial Name: NCT05868304 — N/A
BFR (Other) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05868304 — N/A
Healthy Subjects Patient Testimony for trial: Trial Name: NCT05868304 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How many participants are being enrolled in this investigation?

"Affirmative. The clinicaltrial.gov portal expresses that this trial is still actively recruiting patients, having been posted on May 1st 2023 and updated for the last time on May 10th 2023. 18 individuals are required to partake in the study at a single medical centre."

Answered by AI

Are participants being sought for this experiment at present?

"Affirmative. Clinicaltrials.gov has verified that this medical trial is taking on new participants, with the initial posting going live on May 1st 2023 and last updated on 10th of same month. The research requires 18 volunteers to take part from a single centre."

Answered by AI

Who else is applying?

What state do they live in?
California
What site did they apply to?
Cedar Sinai Kerlan jobe orthopedic institute
What portion of applicants met pre-screening criteria?
Met criteria
How many prior treatments have patients received?
1

Why did patients apply to this trial?

I weigh less than I thought I did. I want to gain muscle efficiently.
PatientReceived 2+ prior treatments

What questions have other patients asked about this trial?

How long will the trial last? Is it paid?
PatientReceived 1 prior treatment
~9 spots leftby Apr 2025